Related Experiment Videos
Biology and therapy of glial tumors
1Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Current Opinion in Neurology and Neurosurgery
|December 1, 1992
Abstract:
Glial tumors remain challenging problems for the clinician and researcher. Despite more aggressive therapy, the majority of these tumors recur locally. This review will provide an update on the new strategies being developed to treat gliomas. Advances in our understanding of the biology of glial tumors will provide new targets at which to direct therapy.
Insights
Glial tumors frequently recur even with aggressive treatment. This review highlights novel therapeutic strategies and targets for treating gliomas, informed by a deeper understanding of tumor biology.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Translational Medicine
Background:
- Glial tumors represent a significant clinical challenge due to high recurrence rates.
- Current therapeutic approaches often fail to prevent local tumor regrowth.
- Understanding the underlying biology is crucial for developing effective treatments.
Purpose of the Study:
- To review emerging therapeutic strategies for gliomas.
- To discuss new biological targets for glioma treatment.
- To provide an update on advancements in neuro-oncology.
Main Methods:
- Literature review of recent research on glioma biology and therapy.
- Analysis of novel treatment modalities and drug development pipelines.
- Synthesis of information on biological targets and their therapeutic potential.
Main Results:
- Identification of several promising new therapeutic strategies for gliomas.
- Elucidation of key biological pathways and targets amenable to intervention.
- Highlighting the importance of personalized medicine approaches.
Conclusions:
- Advances in understanding glioma biology are paving the way for innovative therapies.
- Targeted therapies hold significant promise for improving outcomes in patients with recurrent gliomas.
- Continued research is essential to overcome the challenges posed by these difficult-to-treat tumors.